India  

Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources

Reuters India Wednesday, 10 June 2020
European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like AstraZeneca and Johnson & Johnson.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

European Union European Union Economic and political union of European states

New Payment System Will Challenge Mastercard And Visa [Video]

New Payment System Will Challenge Mastercard And Visa

As many as 20 major EU banks are set to announce details for a new payments initiative in the very near future. This announcement came from Electronic Payments International. Business Insider reports the system is referred to as the Pan European Payment System Initiative (PEPSI). It will process card payments in addition to making fund transfers and mobile payments without using Mastercard's or Visa's network.

Credit: Wochit News    Duration: 00:30Published
Brexit briefing: 178 days until the end of the transition period [Video]

Brexit briefing: 178 days until the end of the transition period

The UK left the European Union on January 31. Here we look at the latest figures and key dates in the ongoing Brexit process. Quote from Sarah Hewin, Chief economist at Standard Chartered, speaking to the Financial Times.

Credit: PA - Press Association STUDIO    Duration: 00:48Published
Brexit briefing: 179 days until the end of the transition period [Video]

Brexit briefing: 179 days until the end of the transition period

The UK left the European Union on January 31. Here we look at the latest figures and key dates in the ongoing Brexit process.

Credit: PA - Press Association STUDIO    Duration: 00:50Published

Johnson & Johnson Johnson & Johnson U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Human trials begin in fortnight, J&J works to ramp up production of affordable Covid vaccine: Top scientist

Johnson & Johnson is preparing the ground for the entry of a vaccine against Covid-19 and is expanding its manufacturing capacity to supply more than one billion..
IndiaTimes
Johnson & Johnson Cease Production Of Lightening Products [Video]

Johnson & Johnson Cease Production Of Lightening Products

The corporation behind Johnson's, Neutrogena, Clean & Clear, and more has just vowed to stop selling two lines of skin-care products used for skin-lightening overseas. On June 19, in the wake of the recent Black Lives Matter uprising, Johnson & Johnson said that it will cease production of two different lines from Asian and Middle Eastern markets that were used for skin-lightening lines.

Credit: Wochit News    Duration: 00:33Published
Band-Aid to Make Black and Brown Flesh-Tone Bandages [Video]

Band-Aid to Make Black and Brown Flesh-Tone Bandages

The Johnson & Johnson-owned company plans to create a range of bandages to "embrace the beauty of diverse skin"

Credit: Cover Video STUDIO    Duration: 00:50Published
Johnson & Johnson Speeds Up Vaccine Timeline [Video]

Johnson & Johnson Speeds Up Vaccine Timeline

Johnson & Johnson plans to start testing its coronavirus vaccine candidate in humans in July. The company said it will move up the timeline by about two months to start clinical trials. Previously the aim was to enter the clinic with the vaccine in September. The study will start in the second half of July and enroll 1,045 healthy volunteers in the US and Belgium. If the vaccine works, Johnson & Johnson has already pledged to distribute it at a nonprofit rate to help end the pandemic.

Credit: Wochit News    Duration: 00:35Published
Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine [Video]

Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine

The early-stage human trial will begin in the second half of July as opposed to its initial forecast of September.

Credit: Cover Video STUDIO    Duration: 00:56Published

AstraZeneca AstraZeneca British-Swedish pharmaceutical company

Sanofi eyes vaccine approval by early 2021 [Video]

Sanofi eyes vaccine approval by early 2021

French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports.

Credit: Reuters Studio    Duration: 01:13Published
AstraZeneca shares down after report it approached Gilead [Video]

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:09Published
AstraZeneca to make billion COVID vaccine doses if tests succeed [Video]

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:20Published
COVID-19 vaccine "won't be expensive", developer says [Video]

COVID-19 vaccine "won't be expensive", developer says

A keenly-watched COVID-19 vaccine will be priced to allow as wide as possible access to it, if it proves successful, and will be made at huge scale to keep costs down and supply up, said the Oxford University professor co-leading its development. Emer McCarthy reports.

Credit: Reuters Studio    Duration: 01:28Published

You Might Like


Related news from verified sources

Shrinking rate of fresh COVID-19 infections creates bizarre problem for vaccine developers

The shrinking number of new infections in former coronavirus hot spots, including Britain, China and many of the hardest-hit regions in the United States, may be...
Mid-Day

China's COVID-19 vaccine candidate shows promise in human trials, CNBG says

China National Biotec Group (CNBG) said on Tuesday its experimental coronavirus vaccine has triggered antibodies in clinical trials and the company plans...
Reuters India

Hospital gets notice for conducting trials of Patanjali drug on COVID-19 patients

Jaipur: Rajasthan's Health Department has served a notice to NIMS hospital here seeking an explanation on conducting trials of Patanjali Ayurved's drug Coronil...
Mid-Day Also reported by •Reuters IndiaIndiaTimes

Tweets about this